Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 |
|---|---|
| Revenue | $180.11M |
| Cost of revenue | $154.55M |
| Gross profit | $25.56M |
| Gross margin | 14.2% |
| Research and development | $320.15M |
| Selling, general and administrative | $182.64M |
| Operating expenses | $502.79M |
| Operating income | −$477.23M |
| Operating margin | -265.0% |
| EBITDA | −$406.54M |
| Income before taxes | −$450.25M |
| Income taxes | $274.00K |
| Net income | −$450.53M |
| Net margin | -250.1% |
| EPS, basic | −$2.98 |
| EPS, diluted | −$2.98 |
| Diluted shares | 150.97M |
Figures describe Cerebras Systems shares, not any token. As of Aug 12, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.
